326 related articles for article (PubMed ID: 17156337)
41. Aminooxypentane-RANTES induces CCR3 activation and internalization of CCR3 from the surface of human eosinophils.
Elsner J; Dulkys Y; Kimmig D; Wells TN; Proudfoot AE; Kapp A
Int Arch Allergy Immunol; 2001; 124(1-3):227-9. PubMed ID: 11306977
[TBL] [Abstract][Full Text] [Related]
42. C-C chemokine receptor 3 antagonism by the beta-chemokine macrophage inflammatory protein 4, a property strongly enhanced by an amino-terminal alanine-methionine swap.
Nibbs RJ; Salcedo TW; Campbell JD; Yao XT; Li Y; Nardelli B; Olsen HS; Morris TS; Proudfoot AE; Patel VP; Graham GJ
J Immunol; 2000 Feb; 164(3):1488-97. PubMed ID: 10640766
[TBL] [Abstract][Full Text] [Related]
43. Eotaxin and CCR3 are up-regulated in exacerbations of chronic bronchitis.
Bocchino V; Bertorelli G; Bertrand CP; Ponath PD; Newman W; Franco C; Marruchella A; Merlini S; Del Donno M; Zhuo X; Olivieri D
Allergy; 2002 Jan; 57(1):17-22. PubMed ID: 11991282
[TBL] [Abstract][Full Text] [Related]
44. Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency.
De Lucca GV; Kim UT; Vargo BJ; Duncia JV; Santella JB; Gardner DS; Zheng C; Liauw A; Wang Z; Emmett G; Wacker DA; Welch PK; Covington M; Stowell NC; Wadman EA; Das AM; Davies P; Yeleswaram S; Graden DM; Solomon KA; Newton RC; Trainor GL; Decicco CP; Ko SS
J Med Chem; 2005 Mar; 48(6):2194-211. PubMed ID: 15771462
[TBL] [Abstract][Full Text] [Related]
45. Chemokine-binding specificity of soluble chemokine-receptor analogues: identification of interacting elements by chimera complementation.
Datta-Mannan A; Stone MJ
Biochemistry; 2004 Nov; 43(46):14602-11. PubMed ID: 15544331
[TBL] [Abstract][Full Text] [Related]
46. Identification of a potent and nonpeptidyl ccr3 antagonist.
Saeki T; Ohwaki K; Naya A; Kobayashi K; Ishikawa M; Ohtake N; Noguchi K
Biochem Biophys Res Commun; 2001 Mar; 281(3):779-82. PubMed ID: 11237726
[TBL] [Abstract][Full Text] [Related]
47. Functional expression and characterization of macaque C-C chemokine receptor 3 (CCR3) and generation of potent antagonistic anti-macaque CCR3 monoclonal antibodies.
Zhang L; Soares MP; Guan Y; Matheravidathu S; Wnek R; Johnson KE; Meisher A; Iliff SA; Mudgett JS; Springer MS; Daugherty BL
J Biol Chem; 2002 Sep; 277(37):33799-810. PubMed ID: 12101185
[TBL] [Abstract][Full Text] [Related]
48. Expression of a functional eotaxin (CC chemokine ligand 11) receptor CCR3 by human dendritic cells.
Beaulieu S; Robbiani DF; Du X; Rodrigues E; Ignatius R; Wei Y; Ponath P; Young JW; Pope M; Steinman RM; Mojsov S
J Immunol; 2002 Sep; 169(6):2925-36. PubMed ID: 12218106
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of CD26/dipeptidyl peptidase IV enhances CCL11/eotaxin-mediated recruitment of eosinophils in vivo.
Forssmann U; Stoetzer C; Stephan M; Kruschinski C; Skripuletz T; Schade J; Schmiedl A; Pabst R; Wagner L; Hoffmann T; Kehlen A; Escher SE; Forssmann WG; Elsner J; von Hörsten S
J Immunol; 2008 Jul; 181(2):1120-7. PubMed ID: 18606664
[TBL] [Abstract][Full Text] [Related]
50. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage.
Oravecz T; Pall M; Roderiquez G; Gorrell MD; Ditto M; Nguyen NY; Boykins R; Unsworth E; Norcross MA
J Exp Med; 1997 Dec; 186(11):1865-72. PubMed ID: 9382885
[TBL] [Abstract][Full Text] [Related]
51. Hepatocyte growth factor attenuates eotaxin and PGD2-induced chemotaxis of human eosinophils.
Ito W; Chiba T; Kanehiro A; Kato H; Yamaguchi K; Ueki S; Kayaba H; Chihara J
Allergy; 2007 Apr; 62(4):415-22. PubMed ID: 17362253
[TBL] [Abstract][Full Text] [Related]
52. Interplay between signaling via the formyl peptide receptor (FPR) and chemokine receptor 3 (CCR3) in human eosinophils.
Svensson L; Redvall E; Johnsson M; Stenfeldt AL; Dahlgren C; Wennerås C
J Leukoc Biol; 2009 Aug; 86(2):327-36. PubMed ID: 19414538
[TBL] [Abstract][Full Text] [Related]
53. Regulation of chemokine receptor expression in eosinophils.
Nagase H; Miyamasu M; Yamaguchi M; Fujisawa T; Kawasaki H; Ohta K; Yamamoto K; Morita Y; Hirai K
Int Arch Allergy Immunol; 2001; 125 Suppl 1():29-32. PubMed ID: 11408769
[TBL] [Abstract][Full Text] [Related]
54. Molecular cloning and functional characterization of Cynomolgus monkey (Macaca fascicularis) CC chemokine receptor, CCR3.
Iino T; Sugimoto H; Watanabe A; Encinas JA; Liu N; Floeckner J; Bacon KB
Cytokine; 2002 Sep; 19(6):276-86. PubMed ID: 12421570
[TBL] [Abstract][Full Text] [Related]
55. A novel LPS-inducible CCR3 activator: why so many CCR3 ligands?
Lilly CM; Daugherty BL
Am J Respir Cell Mol Biol; 2001 Dec; 25(6):673-5. PubMed ID: 11726391
[No Abstract] [Full Text] [Related]
56. Role of Eotaxin-1 (CCL11) and CC chemokine receptor 3 (CCR3) in bleomycin-induced lung injury and fibrosis.
Huaux F; Gharaee-Kermani M; Liu T; Morel V; McGarry B; Ullenbruch M; Kunkel SL; Wang J; Xing Z; Phan SH
Am J Pathol; 2005 Dec; 167(6):1485-96. PubMed ID: 16314464
[TBL] [Abstract][Full Text] [Related]
57. Discovery and structure-activity relationship of N-(ureidoalkyl)-benzyl-piperidines as potent small molecule CC chemokine receptor-3 (CCR3) antagonists.
De Lucca GV; Kim UT; Johnson C; Vargo BJ; Welch PK; Covington M; Davies P; Solomon KA; Newton RC; Trainor GL; Decicco CP; Ko SS
J Med Chem; 2002 Aug; 45(17):3794-804. PubMed ID: 12166951
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of airway inflammation by amino-terminally modified RANTES/CC chemokine ligand 5 analogues is not mediated through CCR3.
Chvatchko Y; Proudfoot AE; Buser R; Juillard P; Alouani S; Kosco-Vilbois M; Coyle AJ; Nibbs RJ; Graham G; Offord RE; Wells TN
J Immunol; 2003 Nov; 171(10):5498-506. PubMed ID: 14607956
[TBL] [Abstract][Full Text] [Related]
59. CCL11 (Eotaxin) induces CCR3-dependent smooth muscle cell migration.
Kodali RB; Kim WJ; Galaria II; Miller C; Schecter AD; Lira SA; Taubman MB
Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1211-6. PubMed ID: 15130922
[TBL] [Abstract][Full Text] [Related]
60. Pharmacological profiling of chemokine receptor-directed compounds using high-content screening.
Haasen D; Merk S; Seither P; Martyres D; Hobbie S; Heilker R
J Biomol Screen; 2008 Jan; 13(1):40-53. PubMed ID: 18227225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
